LA JOLLA MOM IN NEED OF DONATIONS FROM THOSE WITH EXTREMELY RARE BLOOD TYPE
SAN DIEGO (January 25, 2021) – La Jolla resident and mother of three, Stacie Buechel was recently diagnosed with bone cancer and needs blood transfusions as part of her treatment, but her situation is complicated because she has a rare blood type. Stacie needs blood from donors who have A+ (A positive), O- (O negative) or O+ (O positive) blood that also lacks a protein called Kpb. Less than 1% of the population have this type of blood.
More information on Stacie’s story can be found here
Anyone who would like to donate blood in Stacie’s name can visit any San Diego Blood Bank donation location or mobile drive and note the donation code ESSB when registering.
San Diego Blood Bank is currently antibody testing each blood donation as part of their regular testing panel to qualify donations for COVID-19 convalescent plasma. Visit sandiegobloodbank.org/COVID19 for more information. Please note: As this is NOT a diagnostic test, it will not detect active COVID-19 infections or recent exposure.
To be eligible to donate blood you must be at least 17 years old, weigh at least 114 pounds and be in general good health. Appointments are required and available by visiting sandiegobloodbank.org or by calling (619) 400-8251.
About San Diego Blood Bank
SDBB is dedicated to community health by providing a reliable supply of blood to patients in need. Our vision is to further ensure the health of our community by simultaneously delivering related health and wellness education and services and extending into research. SDBB is an independent, 501(c)(3) non-profit that serves hospitals in San Diego, Orange, Imperial and Los Angeles counties with blood transfusion products and reference laboratory services. SDBB currently operates six local donor centers and 10 bloodmobiles. SDBB’s Cell Therapy Program provides lifesaving stem cell transplants to patients worldwide. For more information about SDBB, visit www.SanDiegoBloodBank.org or connect with us on Facebook and Twitter.